Natsar Pharmaceuticals, Inc. — Form D

Natsar Pharmaceuticals, Inc. of ELLICOTT CITY, MD, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-08. $4.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2026-05-08
• Form: D
• Accession: 0002134002-26-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Amount sold: $4.2M
• Minimum investment: $1
• Investors: 15
• Security types: equity
• Revenue range: No Revenues
• SEC file number: 021-583294

Issuer

• Name: Natsar Pharmaceuticals, Inc.
• CIK: 0002134002
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 4624 TALL MAPLE CT., ELLICOTT CITY, MD, 21043
• Phone: 410-948-2578

Officers, directors & promoters (1)

More

• CIK 2134002 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search